Koninklijke Philips N.V.

Koninklijke Philips N.V., commonly known as Philips, is a global health technology company headquartered in Amsterdam, the Netherlands. Its business is organized into three main segments: Diagnosis & Treatment, Connected Care, and Personal Health. The Diagnosis & Treatment segment provides diagnostic imaging solutions, including ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and diagnostic X-ray systems, as well as image-guided therapy systems and devices. The Connected Care segment offers monitoring, enterprise informatics, and sleep and respiratory care solutions. The Personal Health segment focuses on consumer health products. Philips has a strategic alliance with WellSpan Health to advance imaging and diagnostics technology. Founded in 1891, the company rebranded from Koninklijke Philips Electronics N.V. to its current name in May 2013.

Koninklijke Philips N.V. is listed on the New York Stock Exchange (NYSE) under the ticker symbol PHG. Its shares trade in US Dollars (USD). The company is headquartered in Amsterdam, the Netherlands, and its primary listing is on the NYSE, making it accessible to US and international investors. As a foreign private issuer, Philips also reports its financial results in USD for the convenience of its US-based shareholders. The choice of the NYSE and USD trading reflects the company's global reach and its focus on attracting a broad investor base, particularly in the United States, which is a key market for its health technology products.

Koninklijke Philips N.V. operates in the Healthcare sector, specifically within the Medical Devices industry. As a health technology company, Philips focuses on developing and providing innovative solutions that improve patient outcomes and enable efficient healthcare delivery. Its product portfolio spans diagnostic imaging (such as MRI, CT, and ultrasound), image-guided therapy, patient monitoring, enterprise informatics, sleep and respiratory care, and personal health products. By operating in the medical devices industry, Philips competes with other major health technology firms, leveraging its expertise in both hardware and software to address the evolving needs of healthcare providers and consumers worldwide.

Koninklijke Philips N.V. is headquartered in Amsterdam, the Netherlands, and serves global markets. Founded in 1891, the company has a long history of innovation and operates in over 100 countries. Its products and solutions are used by healthcare providers, hospitals, and consumers worldwide. The company's strategic alliance with WellSpan Health, for example, demonstrates its commitment to advancing imaging and diagnostics technology in the US market. Philips' global presence allows it to address diverse healthcare challenges, from developed regions like North America and Europe to emerging markets in Asia and Latin America. The company's headquarters in Amsterdam serves as the central hub for its worldwide operations, including research, development, and corporate functions.

Koninklijke Philips N.V. generates revenue through the sale of health technology products and services across its three segments: Diagnosis & Treatment, Connected Care, and Personal Health. The Diagnosis & Treatment segment contributes by selling diagnostic imaging systems (e.g., MRI, CT, ultrasound) and image-guided therapy equipment, as well as related services and software. The Connected Care segment earns revenue from patient monitoring devices, enterprise informatics solutions, and sleep & respiratory care products. The Personal Health segment includes consumer-oriented products like electric toothbrushes, shavers, and other health-related appliances. Additionally, Philips generates recurring revenue from service contracts, maintenance, and subscription-based software offerings. The company's strategic partnerships, such as with WellSpan Health, also drive revenue through collaborative projects and long-term supply agreements.